Literature DB >> 20201760

CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement.

Peter G Gibson1, Anne B Chang, Nicholas J Glasgow, Peter W Holmes, Peter Katelaris, Andrew S Kemp, Louis I Landau, Stuart Mazzone, Peter Newcombe, Peter Van Asperen, Anne E Vertigan.   

Abstract

Cough is a common and distressing symptom that results in significant health care costs from medical consultations and medication use. Cough is a reflex activity with elements of voluntary control that forms part of the somatosensory system involving visceral sensation, a reflex motor response and associated behavioural responses. At the initial assessment for chronic cough, the clinician should elicit any alarm symptoms that might indicate a serious underlying disease and identify whether there is a specific disease present that is associated with chronic cough. If the examination, chest x-ray and spirometry are normal, the most common diagnoses in ADULTS are asthma, rhinitis or gastro-oesophageal reflux disease (GORD). The most common diagnoses in CHILDREN are asthma and protracted bronchitis. Management of chronic cough involves addressing the common issues of environmental exposures and patient or parental concerns, then instituting specific therapy. In ADULTS, conditions that are associated with removable causes or respond well to specific treatment include protracted bacterial bronchitis, angiotensin-converting enzyme inhibitor use, asthma, GORD, obstructive sleep apnoea and eosinophilic bronchitis. In CHILDREN, diagnoses that are associated with removable causes or respond well to treatment are exposure to environmental tobacco smoke, protracted bronchitis, asthma, motor tic, habit and psychogenic cough. In ADULTS, refractory cough that persists after therapy is managed by empirical inhaled corticosteroid therapy and speech pathology techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201760     DOI: 10.5694/j.1326-5377.2010.tb03504.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  33 in total

1.  Effects of quitting cannabis on respiratory symptoms.

Authors:  Robert J Hancox; Hayden H Shin; Andrew R Gray; Richie Poulton; Malcolm R Sears
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 2.  The role of speech pathology in the management of patients with chronic refractory cough.

Authors:  Anne E Vertigan; Peter G Gibson
Journal:  Lung       Date:  2011-10-12       Impact factor: 2.584

Review 3.  Current Status and Future Directions of Chronic Cough in China.

Authors:  Kefang Lai; Li Long
Journal:  Lung       Date:  2020-01-07       Impact factor: 2.584

Review 4.  Recent additions in the treatment of cough.

Authors:  Nicole M Ryan; Peter G Gibson
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 5.  Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome.

Authors:  Kian Fan Chung
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 6.  Chronic cough and OSA: a new association?

Authors:  Krishna M Sundar; Sarah E Daly
Journal:  J Clin Sleep Med       Date:  2011-12-15       Impact factor: 4.062

Review 7.  Inhaled corticosteroids for subacute and chronic cough in adults.

Authors:  Kate J Johnstone; Anne B Chang; Kwun M Fong; Rayleen V Bowman; Ian A Yang
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

8.  Prevalence and Characteristics of Chronic Cough in Adults Identified by Administrative Data.

Authors:  Robert S Zeiger; Fagen Xie; Michael Schatz; Benjamin D Hong; Jessica P Weaver; Vishal Bali; Jonathan Schelfhout; Wansu Chen
Journal:  Perm J       Date:  2020-12

9.  Overview of the management of cough: CHEST Guideline and Expert Panel Report.

Authors:  Richard S Irwin; Cynthia T French; Sandra Zelman Lewis; Rebecca L Diekemper; Philip M Gold
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

10.  Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy.

Authors:  Nicolaus Schwerk; Folke Brinkmann; Bisharah Soudah; Michael Kabesch; Gesine Hansen
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.